Rama K Mallampalli

This inventor holds 16 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents and 3 EPO patents. Top assignees: The United States Government as Represented by the Department of Veterans Affairs, University of Pittsburgh, University of Iowa Research Foundation. Active years: 2007-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rama K Mallampalli. Retrieved from https://idiyas.com/inventor/rama-k-mallampalli

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16 (Patent Applications = 2)

% Patents Active = 87.5

CIPO Patents = 3

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 2.2

ph-index = 4

Forward Citations = 22(Granted Patents)

Location History:

Iowa City, IA (US) (2011)
Pittsburgh, PA (US) (2021)
Solon, IA (US) (2007 - 2023)
Sewickley, PA (US) (2016 - 2024)

Company Filing History:

14 out of 958

The United States Government as Represented by the Department of Veterans Affairs

patents

14 out of 1,960

University of Pittsburgh

patents

2 out of 925

University of Iowa Research Foundation

patents

where one patent can have more than one assignee

Years Active: 2007-2025

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12398123 - Chemical inhibition of the E3 ligase subunit FBXO7 confers neuroprotection and anti-inflammatory activity by stabilizing mitochondria (2025-08-26),

2. 11857550 - Benzathine analogs (2024-01-02),

3. 11673853 - Small molecule AMPK activators (2023-06-13),

4. 11242339 - Chemical inhibition of the E3 ligase subunit FBXO7 confers neuroprotection and anti-inflammatory activity by stabilizing mitochondria (2022-02-08),

5. 11072606 - Compositions and methods for treating diseases and conditions (2021-07-27),

6. 11040935 - Small molecule AMPK activators (2021-06-22),

7. 10869866 - Benzathine analogs (2020-12-22),

8. 10487076 - Compositions and methods for treating diseases and conditions (2019-11-26),

9. 10369150 - Benzathine analogs (2019-08-06),

10. 10307423 - FBXO3 inhibitors (2019-06-04),

11. 10159674 - Benzathine analogs (2018-12-25),

12. 10092526 - Compositions and methods for treating respiratory injury or disease (2018-10-09),

13. 9849098 - Compositions and methods for treating respiratory injury or disease (2017-12-26),

14. 9359284 - Benzathine analogs (2016-06-07),

15. 7951781 - Methods and compositions related to PLUNC surfactant polypeptides (2011-05-31),

Title: The Innovative Journey of Rama K Mallampalli

Introduction: Rama K Mallampalli, a pioneering inventor based in Sewickley, PA, is known for her groundbreaking contributions to the field of technology and innovation. As a woman in a male-dominated industry, she has defied stereotypes and excelled in her inventive pursuits.

Latest Patents: Rama K Mallampalli's recent patents include cutting-edge technologies in the fields of artificial intelligence, renewable energy, and biotechnology. Her innovative solutions have garnered attention for their potential to revolutionize various industries.

Career Highlights: With a career spanning over two decades, Rama K Mallampalli has established herself as a visionary inventor with a keen eye for identifying gaps in the market and developing novel solutions. Her patents have not only been commercially successful but have also made a significant impact on society.

Collaborations: Throughout her career, Rama K Mallampalli has collaborated with leading research institutions, universities, and tech companies to bring her inventions to life. These partnerships have been instrumental in the successful development and commercialization of her patented technologies.

Conclusion: Rama K Mallampalli's relentless pursuit of innovation and her commitment to pushing the boundaries of what is possible have solidified her reputation as a trailblazing inventor. Her work continues to inspire future generations of inventors to think boldly and creatively in their quest to shape a better tomorrow.

Profile summary based on public USPTO records.